Audit of Platelet Returns at the Golden Jubilee National Hospital (March 2014-March 2015)
International Journal of Cardiovascular and Thoracic Surgery
Volume 3, Issue 4, July 2017, Pages: 23-27
Received: Jun. 8, 2017; Accepted: Jun. 30, 2017; Published: Aug. 16, 2017
Views 1436      Downloads 115
Authors
Diana Jodeh, Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Clydebank, UK
Sanjeet Avtaar Singh, Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Clydebank, UK
Vivian Bader, Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Clydebank, UK
Peter Lang, Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Clydebank, UK
Elaine Harrison, Blood and Transfusion, Golden Jubilee National Hospital, Clydebank, UK
Cathy Collins, Blood and Transfusion, Golden Jubilee National Hospital, Clydebank, UK
Alan Kirk, Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Clydebank, UK
Article Tools
Follow on us
Abstract
Platelet usage during mechanical circulatory support is well described in the literature. However, there is a limited shelf life on platelets. Platelets were required on site when a patient is placed on mechanical circulatory support. We audited the amount of platelet returns in a tertiary referral center for mechanical circulatory support. The standard for platelet wastage was <12% of platelets used as determined by the excellence criteria by NHS Scotland.
Keywords
Mechanical Circulatory Support, Extracorporeal Membranous Oxygenation (ECMO), Platelet Returns
To cite this article
Diana Jodeh, Sanjeet Avtaar Singh, Vivian Bader, Peter Lang, Elaine Harrison, Cathy Collins, Alan Kirk, Audit of Platelet Returns at the Golden Jubilee National Hospital (March 2014-March 2015), International Journal of Cardiovascular and Thoracic Surgery. Vol. 3, No. 4, 2017, pp. 23-27. doi: 10.11648/j.ijcts.20170304.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, et al. Guidelines for the use of platelet transfusions. British Journal of Haematology. 2017; 176(3):365-94.
[2]
Stallion A, Cofer BR, Rafferty JA, Ziegler MM, Ryckman FC. The significant relationship between platelet count and haemorrhagic complications on ECMO. Perfusion. 1994; 9(4):265-9.
[3]
Abrams D, Baldwin MR, Champion M, Agerstrand C, Eisenberger A, Bacchetta M, et al. Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study. Intensive Care Med. 2016; 42(5):844-52.
[4]
John R, Panch S, Hrabe J, Wei P, Solovey A, Joyce L, et al. Activation of endothelial and coagulation systems in left ventricular assist device recipients. The Annals of thoracic surgery. 2009; 88(4):1171-9.
[5]
Gorlinger K, Bergmann L, Dirkmann D. Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol. 2012; 26(2):179-98.
[6]
Himmelreich G, Ullmann H, Riess H, Rosch R, Loebe M, Schiessler A, et al. Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device. ASAIO J. 1995; 41(3): M790-4.
[7]
Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996; 88(8):2939-50.
[8]
Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V, 3rd, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. The Annals of thoracic surgery. 2010; 90(4):1263-9; discussion 9.
[9]
Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009; 53(23):2162-7.
[10]
Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010; 56(15):1207-13.
[11]
Ang AL, Teo D, Lim CH, Leou KK, Tien SL, Koh MB. Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation -- a single centre experience. Vox sanguinis. 2009; 96(1):34-43.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186